You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Use of Suprapubic Tube to Assess Voiding Function After Synthetic Midurethral Slings

Kasturi, Seshadri MBBS*; Cassiere, Erin Kate MD; Bentley-Taylor, Miriam MD; Woodman, Patrick J. DO*; Hale, Douglass S. MD*

Female Pelvic Medicine & Reconstructive Surgery:
doi: 10.1097/SPV.0b013e318254f061
Case Series
Abstract

Introduction: Up to 50% of patients are unable to void immediately after midurethral sling (MUS) procedures. The objective of this study was to present our case series of use of suprapubic tube (SPT) to assess voiding function after MUS procedures.

Methods: This was a retrospective cohort study of patients who underwent MUS procedures along with insertion of SPT between January 2007 and August 2010.

Results: A total of 123 patients were identified. Among the patients who met criteria for SPT removal within 4 weeks, the mean number of days of SPT use was 6 (4.6) days. One major complication involved a urinoma after SPT removal.

Conclusion: The use of SPT after MUS procedures is practical. In our cohort of patients, it took up to 1 week for voiding function to return to normal.

In Brief

This is a retrospective study of patients who underwent suprapubic tube (SPT) placement with midurethral sling procedures to assess voiding function.

Author Information

From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, †Department of Obstetrics and Gynecology, Indiana University, Indianapolis, IN; and ‡Department of Obstetrics and Gynecology, William Beaumont Hospital, Royal Oak, MI.

Reprints: Seshadri Kasturi, MBBS, 1633 N Capitol Ave, Suite 436, Indianapolis, IN 46214. E-mail: seshkasturi@yahoo.com.

Conflict of interests and financial disclosure: Seshadri Kasturi, Erin Kate Cassiere, and Miriam Bentley-Taylor have no conflicts of interest or financial disclosure to declare. Patrick J. Woodman is speaker for Pfizer, recipient of a research grant from Ethicon Women’s Health and Urology. Douglass S. Hale is consultant for Ethicon Women’s Health and Urology, and a researcher for Allergan.

Authors’ participation in this work:

Kasturi: project development, data collection, manuscript writing, manuscript editing; Cassiere: data collection, manuscript writing; Bentley-Taylor: data collection, manuscript writing; Woodman: project development, manuscript editing; Hale: project development, manuscript editing.

© 2012 by Wolters Kluwer Health | Lippincott Williams & Wilkins